Millennium Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-14,130
| Closed | -$3K | – | 4479 |
|
|
2018
Q1 | $3K | Buy |
+14,130
| New | +$13K | ﹤0.01% | 3580 |
|
|
2017
Q1 | – | Sell |
-15,823
| Closed | -$28K | – | 4162 |
|
|
2016
Q4 | $28K | Sell |
15,823
-25,912
| -62% | -$60.9K | ﹤0.01% | 3272 |
|
|
2016
Q3 | $139K | Sell |
41,735
-23,665
| -36% | -$89.4K | ﹤0.01% | 3068 |
|
|
2016
Q2 | $281K | Buy |
65,400
+60,422
| +1,214% | +$273K | ﹤0.01% | 2763 |
|
|
2016
Q1 | $28K | Sell |
4,978
-343,773
| -99% | -$4.46M | ﹤0.01% | 3187 |
|
|
2015
Q4 | $6M | Sell |
348,751
-45,246
| -11% | -$1.08M | 0.01% | 1239 |
|
|
2015
Q3 | $8.31M | Sell |
393,997
-70,533
| -15% | -$2.42M | 0.02% | 1038 |
|
|
2015
Q2 | $23M | Buy |
464,530
+239,760
| +107% | +$14.3M | 0.04% | 563 |
|
|
2015
Q1 | $17.6M | Buy |
224,770
+130,217
| +138% | +$8.08M | 0.03% | 728 |
|
|
2014
Q4 | $5.73M | Buy |
+94,553
| New | +$4.75M | 0.01% | 1299 |
|
|
2014
Q3 | – | Sell |
-19,078
| Closed | -$1.18M | – | 4376 |
|
|
2014
Q2 | $1.18M | Sell |
19,078
-185,879
| -91% | -$10.8M | ﹤0.01% | 2106 |
|
|
2014
Q1 | $13.3M | Sell |
204,957
-44,944
| -18% | -$3.04M | 0.04% | 640 |
|
|
2013
Q4 | $14.1M | Buy |
249,901
+219,390
| +719% | +$12.3M | 0.04% | 518 |
|
|
2013
Q3 | $1.87M | Buy |
30,511
+28,406
| +1,349% | +$1.92M | 0.01% | 1728 |
|
|
2013
Q2 | $123K | Buy |
+2,105
| New | +$130K | ﹤0.01% | 2846 |
|
Other funds holding OREX
Millennium Management's OREX Position: Q2 2018 in Review
Millennium Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 14,130 shares — an estimated $3K sold.
Millennium Management first reported a position in OREX in Q2 2013 and held it in 15 quarters. The position peaked at $23M in Q2 2015. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.
- Millennium Management reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- Millennium Management sold 14,130 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $3K.
- Millennium Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 15 quarters.
- Millennium Management's Orexigen Therapeutics, Inc. position peaked at $23M in Q2 2015.
- 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.
Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.